I'ROM GROUP CO LTD 2372

2372 TSE
2372
I'ROM GROUP CO LTD TSE
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

2372 Chart

Trade 2372 with trusted brokers on TradingView Open account
Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Health Services
Industry: Medical/Nursing Services
I'rom Group Co., Ltd. engages in the medical support business. It operates through the following business divisions: Advanced Medicinal Treatment Services, Site Management Organization (SMO) Services, Contract Research Organization (CRO) Services and Medical Support Business. The Advanced Medicinal Treatment Services division engages in the development of advanced medical technologies such as regenerative medicine and gene therapy to the practical level has been long awaited. The SMO services division conducts clinical trials, various operations, besides examinations and tests, arise at the medical institutions, including data organization and document management. The CRO Services division provides clinical trials of pharmaceuticals or medical devices in the development stage or in post-marketing clinical trials. The Medical Support Business division supports the enhancement of convenience and quality of medical care for patients by providing clinic malls. The company was founded on April 9, 1997 and is headquartered in Tokyo, Japan.